Status:
COMPLETED
Impact of Artificial Intelligence Genius® System-assisted Colonoscopy vs. Standard Colonoscopy (COLO-GENIUS)
Lead Sponsor:
Clinique Paris-Bercy
Conditions:
Colonic Polyp
Colonoscopy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This controlled-randomized trial compares the artificial intelligence Genius® system assisted (Genius+) to standard (Genius-) colonoscopy. The aim of this study was to evaluate the impact of Genius® ...
Detailed Description
Any patient seen by gastroenterologists working in the endoscopy unit and meeting the inclusion criteria may be recruited. The patient will be offered to participate in the study. The information for...
Eligibility Criteria
Inclusion
- Patient scheduled for total colonoscopic exploration, during the period study
- Patient over or equal to 18 years
- ASA 1, ASA 2, ASA 3
- No participation in another clinical study
- Certificate of non opposition signed
Exclusion
- Patient under 18 years old
- ASA 4, ASA 5
- Pregnant woman
- Patient with coagulation abnormalities preventing polypectomy: prothrombin level \<50%, Platelets \<50000 / mm3, effective anti-coagulation in progress, clopidogrel in progress.
- Patient referred for resection of a known polyp
- Inflammatory bowel disease
- Known colonic stenosis
- Diverticulitis less than 6 weeks old
- Patient unable to give consent or protected by law
- Opposition expressed for inclusion in the study
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2022
Estimated Enrollment :
2100 Patients enrolled
Trial Details
Trial ID
NCT04440865
Start Date
February 1 2021
End Date
April 20 2022
Last Update
May 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Paris-Bercy
Charenton-le-Pont, France, 94220